-+ 0.00%
-+ 0.00%
-+ 0.00%

ENLIVEN THERAPEUTICS, INC. : GUGGENHEIM CUTS TARGET PRICE TO $78 FROM $80

Reuters·08/06/2026 02:35:10

Please log in to view news